Accretive Health
AH
AH was delisted on the 14th of March, 2014.
5 hedge funds and large institutions have $18.8M invested in Accretive Health in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
60% more capital invested
Capital invested by funds: $11.8M → $18.8M (+$7.01M)
17% less funds holding
Funds holding: 6 → 5 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LM
Litespeed Management
New York
|
+$8.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
-$3.05M |
| 2 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$975K |
| 3 |
RMC
Regis Management Company
Menlo Park,
California
|
-$256K |
| 4 |
Neuberger Berman Group
New York
|
-$189K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$2K |
AH Hedge Fund Activity: Q4 2015 in Review
5 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q4 2015, worth a combined $18.8M — up 60% from $11.8M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of AH and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 0 added.
The largest buyer was Litespeed Management, opening a new position worth an estimated $8.95M. The largest seller was GMT Capital, exiting entirely with an estimated $3.05M sold.
- 5 institutional investors held Accretive Health (AH) as of Q4 2015, down from 6 in Q3 2015.
- Funds reported $18.8M of Accretive Health stock for Q4 2015, up 60% quarter-over-quarter.
- 1 fund opened new Accretive Health positions in Q4 2015 and 2 closed out, a net change of -1 holder.
- The largest Accretive Health buyer in Q4 2015 was Litespeed Management, an estimated $8.95M added.
- The largest Accretive Health seller in Q4 2015 was GMT Capital, an estimated $3.05M sold.
Based on aggregated 13F filings for Q4 2015.